These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32120039)

  • 1. Elimination of viral hepatitis: where do we stand in the year 2020?
    Maticic M; Mondelli MU
    Clin Microbiol Infect; 2020 Jul; 26(7):816-817. PubMed ID: 32120039
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral hepatitis elimination: Towards a hepatitis-free world.
    Buti M; Craxi A; Foster GR; Maticic M; Negro F; Zeuzem S; Zoulim F
    J Hepatol; 2022 Nov; 77(5):1444-1447. PubMed ID: 35907517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No more excuses: viral hepatitis can be eliminated.
    Locarnini S; Chen DS; Shibuya K
    Lancet; 2016 Apr; 387(10029):1703-4. PubMed ID: 27116263
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral hepatitis: impressive advances but still a long way to eradication of the disease.
    Marcellin P; Asselah T
    Liver Int; 2014 Feb; 34 Suppl 1():1-3. PubMed ID: 24373070
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis A, B, and C.
    Christenson JC; Manaloor JJ
    Pediatr Rev; 2016 Oct; 37(10):426-438. PubMed ID: 27694120
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis elimination by 2030: Progress and challenges.
    Waheed Y; Siddiq M; Jamil Z; Najmi MH
    World J Gastroenterol; 2018 Nov; 24(44):4959-4961. PubMed ID: 30510370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis elimination: a challenge, but within reach.
    The Lancet
    Lancet; 2022 Jul; 400(10348):251. PubMed ID: 35871799
    [No Abstract]   [Full Text] [Related]  

  • 8. Findings of the midterm review of the implementation of the global health sector strategy and regional action plan for viral hepatitis.
    East Mediterr Health J; 2020 Apr; 26(4):487-488. PubMed ID: 32338368
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of Coronavirus Disease 2019 Pandemic on Viral Hepatitis Elimination: What Is the Price?
    Sowah L; Chiou C
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):585-588. PubMed ID: 33913731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calls get louder for global action on silent hepatitis crisis.
    Morris K
    Lancet Infect Dis; 2013 Aug; 13(8):657-8. PubMed ID: 24049780
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral hepatitis in 2021: The challenges remaining and how we should tackle them.
    Dunn R; Wetten A; McPherson S; Donnelly MC
    World J Gastroenterol; 2022 Jan; 28(1):76-95. PubMed ID: 35125820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forgotten, not neglected: viral hepatitis in resource-limited settings, recall for action.
    Lemoine M; Thursz M; Njie R; Dusheiko G
    Liver Int; 2014 Jan; 34(1):12-5. PubMed ID: 23998284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phases of hepatitis C elimination: achieving WHO elimination targets.
    Pedrana A; Munari S; Stoové M; Doyle J; Hellard M
    Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):6-8. PubMed ID: 33308435
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of COVID-19 on hepatitis elimination.
    Wingrove C; Ferrier L; James C; Wang S
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):792-794. PubMed ID: 32730783
    [No Abstract]   [Full Text] [Related]  

  • 15. Time to act to make elimination of viral hepatitis a reality.
    Kasai T
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):102-103. PubMed ID: 31852633
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination.
    Naggie S; Wyles D
    J Infect Dis; 2020 Nov; 222(Suppl 9):S741-S744. PubMed ID: 33245351
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathway to Hepatitis Elimination and Control.
    Lim SG; Lee GH
    Ann Acad Med Singap; 2018 Nov; 47(11):435-437. PubMed ID: 30578421
    [No Abstract]   [Full Text] [Related]  

  • 18. [The WHO program for controlling viral hepatitis].
    Gendon IuZ
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):118-22. PubMed ID: 3057774
    [No Abstract]   [Full Text] [Related]  

  • 19. Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030.
    Howell J; Pedrana A; Cowie BC; Doyle J; Getahun A; Ward J; Gane E; Cunningham C; Wallace J; Lee A; Malani J; Thompson A; Hellard ME
    J Gastroenterol Hepatol; 2019 Jan; 34(1):40-48. PubMed ID: 30151932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report from a Viral Hepatitis Policy Forum on implementing the WHO Framework for Global Action on viral hepatitis in North Asia.
    Chen DS; Locarnini S; Wait S; Bae SH; Chen PJ; Fung JY; Kim HS; Lu SN; Sung J; Tanaka J; Wakita T; Ward J; Wallace J;
    J Hepatol; 2013 Nov; 59(5):1073-80. PubMed ID: 23850942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.